However, in patients with type 2 diabetes, plasma levels of glucagon remain abnormally high after ingestion of a meal and may contribute to impaired glucose tolerance further suggesting that the cAMP signaling pathway is upregulated in insulin-resistant individuals [12, 16, 17]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.